Skip to main content

Table 2 Mean values for quality of life sub-scales by systemic adjuvant treatment.*

From: Quality of life of 5–10 year breast cancer survivors diagnosed between age 40 and 49

 

Chemotherapy + Hormonal Therapy

N = 59

Chemotherapy N = 59

Hormonal Therapy

N = 21

No Systemic Adjuvant Therapy

N = 76

P-value†

SF-36 sub scales

   Physical Functioning

75.6

78.7

85.5

84.5

.08

   Role Function-Physical

62.5

72.8

75.0

81.7

.02

   Bodily Pain

67.7

69.6

72.6

75.4

.10

   General Health

63.4

68.8

73.6

73.8

.05

   Vitality

47.4

54.6

51.5

56.3

.12

   Social Functioning

73.7

74.6

76.9

83.7

.01

   Role Function-Emotional

69.1

66.7

60.0

76.8

.07

   Mental Health

68.3

70.2

69.0

72.8

.16

SF-36 PCS

45.5

48.0

50.9

50.7

.05

SF-36 MCS

45.9

46.3

44.4

48.3

.14

CESD

13.1

11.7

12.0

10.8

.33

CARES-SF sub scales

   CARES Physical

0.6

0.6

0.5

0.3

<.01

   CARES Medical

0.4

0.6

0.3

0.4

.29

   CARES Psychosocial

0.7

0.8

0.7

0.6

.02

   CARES Sexual

1.8

1.8

1.2

1.0

<.01

   CARES Marital

0.7

0.8

0.4

0.4

.01

   CARES Global

0.7

0.7

0.6

0.5

<.01

  1. *Scoring: SF-36 subscales 0 to 100 with higher scores indicating higher QOL; CESD 0 to 60 with higher score indicating more depressive symptoms; CARES-SF 0–4 with higher score indicating more difficulty or impairment. † P value is for the comparison of women who received any adjuvant therapy to those who received no adjuvant therapy based on ANOVA.